MAINTENANCE THERAPY FOR HOSPITAL OUT-PATIENTS by Chakraborty, Ajita et al.
Indian J. Psychiat (1991), 33 (4) 286-290 
MAINTENANCE THERAPY FOR HOSPITAL OUT-PATIENTS 
AJITA CHAKRABORTY, 1, PABITRA DUTTA2, BAPPADITYA DEB3 
Summary 
A study of dosage requirements undertaken among chronic OPD patients found on unnecessarily high drug dosage 
regimes. Basing on OPD experiences authors discuss long term treatment strategies and strongly advocate low dose 
intermittent oral therapy. 
In keeping with the view of many 
trans-culturists that there is an ethnic variation 
in drug response, Chakraborty (1970) had 
reported low dosage requirement of Bengali 
patients. In an endeavour to establish the 
minimum effective dose (ibid) and to set a 
guideline for out-patient treatment a study was 
undertaken and briefly reported (Chakraborty 
et al., 1982). The recent interest in low dose 
and intermittent neuroleptic treatment has 
prompted us to update the data and start a new 
series. 
Material and Method 
202 patients were selected from all patients 
receiving treatment at the psychiatric OPD of 
a large general hospital (where they were 
thought to be on a high dosage schedule). 
Selection criteria were- a) at least 3 years 
duration of drug treatment at this OPD, b) 
more or less stable condition, c) regularity of 
attendance. 
Besides the usual demographic details, 
protocols were maintained to record 
(a) withdrawal symptoms, (b) subjective 
distress, (c) prodromal symptoms of relapse, 
(d) relapse. And the global rating of progress 
on a 5 point scale from " relapse to stability", 
assessed from both patients and relative's 
reports. 
At the start of the trial all the patients were 
clinically examined again to determine 
whether they did require the amount of 
psychotropic drugs they were receiving. On 
the basis of this assessment, drugs were not 
reduced in 15 patients; in others the drugs 
were reduced straightaway by half to one 
fourth of the original dose. The patients were 
followed-up at weekly interval for 3 months, 
then at monthly interval for nine months (total 
one year). Reassurances and psychotherapy 
were undertaken for withdrawal symptoms 
and subjective distress. For prodormal 
symptoms of relapse drugs were rapidly 
increased, for full relapse ECT was also 
given.The aim was to restore the patients 
atleast to their previous level of functioning or 
well-being on a lower dosage schedule. 
Keeping the ethical aspects in mind good care 
was taken of these patients. 
Regression analysis usuing computer was 
done. 
Results 
Of the 202 patients full or consistent data 
could be obtained from 150 patients only. The 
rest (52) remained as a part of the study but 
their data was not analysed because of the 
following reasons - a) remained well without 
drugs ; b) supplemented drugs on their own; c) 
relatives turned un-cooperative; d) dropped 
out for long stretches. 
Reductions were achieved within the first 
six weeks, later adjustment were made. 
Relapses occurred in 12% of the cases, 
improvements were quick with enhancement 
of dosage but 1 or 2 ECTs were required in 3 
cases. Complaints of distress and withdrawal 
symptoms came mostly from the 
antidepressive group (which included many 
obsessionals), these gradually settled with 
minor adjustments and reassurances. Once 
stabilised most patients welcomed the lower 
schedule. The following table sums up the 
amount of reductions that could be made with 
success. 
Levels of dose reduction achieved 
A. Neuroleptic group - Chlorpromazine 
equivalents - mg/day 
B. Anu-depressive group - Impiramine -
mg/day 
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Original Reduction Reduction At end of trial 
range of not tried tried 
dose 
Original Stabilised at 
dose reduction level 
restored upto30% upto 31-45% Over 45% 
A 50-200 3 27 5 1 2 19 
210-400+ 5 21 3 5 6 7 
48(100%) 8(16.6%) 6(12.5%) 8(16.6%) 26(54.1%) 
B 50-150 7 76 10 14 22 30 
160-300 11 1 3 16 
87(100%) 11(12.6%) 17(19.5%) 23(26.4%) 36(41.3%) 
It will be seen that for both the groups, 
through the whole range, drugs could be 
reduced by one third to half of the original 
dose. At the end of the trial majority of the 
patients were stabilised on 50 mg to 100 mg 
of chlorpromazine equivalents or 25 mg to 75 
mg of imipramine per day. Successful 
reductions were directly proportional to the 
initial dose in the case of anti-depressives and 
to the duration of treatment in the case of 
neuroleptics. These findings were significant 
in regression equation (table not given). 
Anti-cholinergics and diazepams were also 
drastically reduced and formed part of the 
study, but that data and other analysis of 
correlates are omitted here as not being of 
general relevance. Suffice it to say that 
maximum resistance and complaints came 
with the reduction of diazepam; though it was 
difficult to distinguish the withdrawal effects 
of diazepam from that of anti-depressives, 
enhancement of the latter removed many 
complaints. Elderly ladies on these drugs for 
years seemed to develop hospital addiction as 
well many came from long distances by train 
(free-trippers presumably !). Dyskinesias and 
other side-effects were not found to be a 
problem, probably because long-acting drugs 
and haloperidol were not being used. 
Further observaions 
Following are some observations made 
during the study taking all aspects of OPD 
treatment including the new cases into 
account References cited indicate support for 
these impressions. By patients we refer, 
irrespective of diagnosis, to those fairly recent 
illness, who had not been exposed to much 
medications. 
a) Almost 80% of the OPD first attenders 
respond immediately to treatment Those who 
do not make significant recovery within three 
.months are likely to need maintenance 
treatment. Good responders remain true to 
form for subsequent relapses. 
b) Patients unused to medication respond to 
very low doses of drugs. The reverse is also 
true, previous exposures build up tolerance 
(unless specially sensitive) calling for high 
dose. 
c) There is great individual variation in drug 
response, even 1 mg of trifluperazine or 10 mg 
of amitryptiline may show favourable 
response or intolerance. This fact is 
exemplified by the broad therapeutic range of 
psychotropic drug, eg. 10 mg to 300 mg of 
thioridazine etc. (Mc Intyre & Gershon, 1985). 
We are in broad agreement with low dose 
treatment policies suggested by Ortiz and 
Gershon (1986), but the upper limits of 
neuroleptic drugs in our patients were found to 
be lower, e.g, chlorpromazine/thioridazine -
300 mg or trifluperazine/halopcridol - 30 mg, 
than that suggested by them (there are rare 
exceptions; a girl of 22 was once seen 
receiving daily haloperidol 40 mg and 
cholorpromazine - 300 mg with anti 
cholinergic and diazepam. She was also on 288  AJTTA CHAKRABORTY et aL 
parenteral fluphenazine - 25 mg every ten 
days. She was quiet, but without therapeutic 
benifit or side -effects !). 
d) Patients are seldom fully compliant, they 
often adjust doses to suit their individual sense 
of comfort (Van Putten, 1974). Some patients 
on neuroleptics will relapse or have 
exacerbations irrespective of the amount of 
medication they receive at the time (Johnson, 
1985). When a patient does not respond to a 
drug, higher doses will not help (Ortiz and 
Gershon, 1986), but a change of drug may do. 
The transition period may entail 
polypharmacy, however, initiating treatment 
with more than one drug of the same group 
serves no purpose whatsoever. 
e) Classical depression with dejected mood, 
delusions, psycho-motor retardation etc. are 
rare in our OPDs, most cases of depression 
(including that of bipolar disorders) present as 
a mixed bag of neuroses. Habituation and 
dependence on anti-depressive drugs occur 
very easily and quickly. However, though 
patients welcome drugs that give them sleep, 
there is a very strong resistance against all 
drugs, particularly 'sleeping pills'. 
0 Chronic patients many years on 
medication lose all distinguishing diagnostic 
features. In such a condition drugs are almost 
interchangeable, e.g. we found reduction of 50 
mg of imipramine bringing on frank 
schizophrenic relapse, which again responded 
to imipramine (Hirsch, 1989). 
Discussion 
The perforce design of the study does not 
allow is to claim that the dosage requirements 
of our patients have been established : we 
found, to achieve that it is necessary to initiate 
treatment accordingly, which is part of our 
ongoing project. The dosage arrived at in the 
present study is, probably similar to what is 
being currently used at many centres. But our 
patients had been receiving higher doses, on 
the average of six years prior to the trial, 
which was largely unnecessary. 
Several surveys of prescribing habits have 
found that polypharmacy and over-medication 
are very common as are inappropriate and 
unnecessary prescriptions (Edwards and 
Kumar, 1984; Clark & Holden, 1987; Muijen 
& Silverstone, 1987). The survey by Bagadia 
and his team (1982) suggest wide variation in 
dosage scheduled used by the Indian 
psychiatrists. Channabasavanna (1988) has 
recently cautioned against irresponsible drug 
prescriptions. 
It goes without saying over-medication is 
highly unethical, besides being financially 
burdensome, it encourages dependence on 
drugs, and most important, produces 
iatrogenic diseases. The alarming increase of 
the latter has now forced all concerned to 
recommend smaller doses, 'drug holidays' and 
'safer' drugs. 
We believe that a cultural factor is operative 
behind the shifting perspective of drug 
treatment. Indian medical tradition, which had 
based itself on subtle clinical signs (now being 
rediscovered in alternate systems), and 
incorporated chronobiology in its practice, 
paid a great deal of attention to dosage of 
drugs. In ayurveda drugs had to be prepared 
for each patients individually in the correct 
dose (matra), excess (matradhykya) was said 
to increase bodily heat which in turn gave rise 
to further malfunction. In the early days our 
allopathic doctors also kept to this tradition. In 
fact, wherever clinical acumen was the sole 
standby, patients were given the "correct" 
dose, and the response and effectiveness 
created the "ethnic effect" mentioned earlier. 
However, the Western cultural influence of 
enthusiastic, over-optimistic, and agressive 
treatment policies in search of the 'holy grail' 
of cure (McClelland, 1989) made all to lose 
sight of the clinical considerations. It could 
well be that such a war-like attidue towards 
death and disease is linked to Judeo-Christian 
philosophies, in contrast to "acceptance" 
preached by the Eastern ones (Chakraborty, 
1967). 
These matters are discussed here to 
emphasize the view that we have to look at 
our conditions objectively before adopting 
even the revised orientations and treatment 
based on experience gained elsewhere. 
In India the great majority of mentally ill 
persons under treatment receive it from 
hospital out-patients departments. These 
OPDs are over-crowded and under-staffed 
(mostly with junior staff at that), the ideal, the 
expensive and the difficult measures are not 
within the ambit of the OPDs. Yet this vital 
sector of our psychiatric services carry heavy 
responsibilities, because, besides being the MAINTENANCE THERAPY 
main teaching ground (in-patients facilities 
being negligible), OPDs in the long run are 
likely to provide the imprint of what 
psychiatry is to the population. It has to be 
remembered 50% of the ever increasing 
volume of the patients catered for in the OPDs 
are rural folks from the surrounding areas of 
urban hospitals (Chakraborty & Sengupta, 
1977). Hence it is important to have well 
thought out policies for OPDs not only fa-
patients regarding treatment but also for 
trainee psychiatrists regarding their roles and 
responsibilities. 
It is of foremost importance to build a sense 
of trust and confidence towards the doctors 
among these out patients. It is equally 
important not to foster the impression that 
hospital doctors prescribe high doses of 
medicines indiscriminately and for indefinite 
periods. Such measures indicate 'incurability* 
of mental disorders, which may be belied by 
the people's own experiences. 
We strongly feel that it is not justified to 
put all patients who receive treatment at the 
OPDs on long-term maintenance therapy. 
Patients should be encouraged to attend and 
follow instructions but the good prognosis 
patients should be discharged after a period 
with advice to report if and when prodormal 
symptoms of relapse appear. Caution is more 
necessary with anti-depressive drugs as 
habituation far out-weigh the risk of the odd 
suicide these may possibly prevent. 
These recommendations are justified by the 
following arguments. Firstly, we found that 
60% of those who register at the OPD 
drop-out after the second visit, it is only a 
fraction of the total number who ever register 
become regular or follow insturctions. It is our 
strong impression that the 'drop-outs' get 
better, either through self-medication or 
through social and natural process. So, we 
contend that only a small proportion of 
psychotics require long-term medication. 
Secondly, it has been established that 
schizophrenia in India carry better prognosis 
(Verghese et al., 1989); it has also been found 
that chronicity of all mental disorders treated 
or untreated among Indians are low (Murphy 
& Raman, 1971; Chakraborty, 1990). 
To return to our recommendation: patients 
for maintenance therapy can be broadly 
divided into two groups: those who show a 
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relentlessly downward course or get into 
unresponsive arrested states and those who 
frequent relapses. It would have helped 
matters a great deal if the latter group could be 
detected at a very early stage. It appears that 
patients who show quick response with low 
dosage have better prognosis in the sense that 
their relapses also show this response. Still, 
there is no denying that even among these 
patients, some will gradually become more 
dysfunctional and have very frequent relapses 
and may develop strong antipathy towards 
drugs. We feel, at present there is no other 
way than trial to detect this pattern of illness. 
As an answer to ethical questions about 
allowing patients to relapse we may restate 
what is common knowledge that relapses 
occur frequently with medication, but these 
may not occur in 5-10 years even without 
medication, hence benefit of the doubt should 
go to those who will do well. Verghese and 
others (1989) have found drug compliance as 
one of the factors associated with good 
outcome in Indian patients, but they have also 
shown that all the significant variables jointly 
account for only 21.8% of the variations in 
multiple regression analysis. It is also to be 
noted that the outcome of schizophrenia is 
much better in India and Nigeria where care 
(including drug treatment) is likely to be much 
less than in Denmark or UK where the 
outcome has been found to be poor (Sartorious 
et al., 1977). The factor that Indians have in 
common with Nigerians may well be social 
tolerance or abundance of sunlight or low 
exposure to chemical substances. Whatever 
may the factors be, endeavour has to be made 
to preserve and identify this inherent 
'immunity'. Hence "prevent relapse at all 
cost" with costly drugs in ever increasing 
dosage should not be our aim. 
The question of diagnosis has not been 
brought into the discussion because it is the 
atypical cases with uncertian diagnosis who 
have good prognosis and fit in better with our 
scheme. It is likely that this group is larger 
than the 'classical' cases. There is no question 
that clear cut cases of manic-depressive 
psychosis call for appropriate treatment and 
preventive measures with lithium and 
carbamezapine, similarly schizophrenia with 
distrubing symptoms and bad prognostic signs 
may require long-acting drugs (an area not 290  AJITA CHAKRABORTY et aL 
ched by the previous discussions), but where 
diagnosis cannot be made with certainty, 
treatment has to be oriented towards the 
symptoms and the course of the illness. 
The training of psychiatrists have been 
mentioned; targetted treatment as indicated 
should make them more aware of clinical 
variations among patients, casual "Repeat All" 
prescriptions for months on end is a disservice 
to themselves as well as to the patients. 
Attempts at prognostication should always be 
encouraged, these may be just guessing games 
to start with but may eventually yeild rewards. 
Finally, no maintenance therapy is possible 
without some interaction with patients, in 
whatever way psychotherapy is imparted this 
should never be lost sight of. 
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